671 related articles for article (PubMed ID: 18642282)
1. MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Chen Y; Zhang W; Geng N; Tian K; Jack Windsor L
Head Neck; 2008 Sep; 30(9):1237-45. PubMed ID: 18642282
[TBL] [Abstract][Full Text] [Related]
2. [The role of matrix metalloproteinases and their tissue inhibitors in oral lichen planus].
Zhang WP; Chen Y; Geng N; Tian K; Bao DM; Yang MZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):420-1. PubMed ID: 17067460
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4.
Kim SG; Chae CH; Cho BO; Kim HN; Kim HJ; Kim IS; Choi JY
J Oral Pathol Med; 2006 Jan; 35(1):37-45. PubMed ID: 16393252
[TBL] [Abstract][Full Text] [Related]
5. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
6. The roles of matrix metalloproteinases-2, -7, -10 and tissue inhibitor of metalloproteinase-1 in the pathogenesis of oral lichen planus.
Rubaci AH; Kazancioglu HO; Olgac V; Ak G
J Oral Pathol Med; 2012 Oct; 41(9):689-96. PubMed ID: 22554030
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
8. Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Cell Biochem; 2006 Apr; 97(5):1036-51. PubMed ID: 16294321
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
10. The imbalanced expression of matrix metalloproteinases in nephrogenic systemic fibrosis.
Kelly BC; Markle LS; Vickers JL; Petitt MS; Raimer SS; McNeese C
J Am Acad Dermatol; 2010 Sep; 63(3):483-9. PubMed ID: 20708474
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
12. Field cancerization in oral lichen planus.
Mignogna MD; Fedele S; Lo Russo L; Mignogna C; de Rosa G; Porter SR
Eur J Surg Oncol; 2007 Apr; 33(3):383-9. PubMed ID: 17084578
[TBL] [Abstract][Full Text] [Related]
13. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
14. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa.
Danielsson K; Wahlin YB; Coates PJ; Nylander K
J Oral Pathol Med; 2010 Sep; 39(8):639-44. PubMed ID: 20618616
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms.
Mazzarella N; Femiano F; Gombos F; De Rosa A; Giuliano M
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):953-7. PubMed ID: 16922944
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
20. Premalignant nature of oral lichen planus.
Laeijendecker R; van Joost T; Kuizinga MC; Tank B; Neumann HA
Acta Derm Venereol; 2005; 85(6):516-20. PubMed ID: 16396800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
